CORDIS' YEAR-END RESULTS FUEL CONTINUED INVESTOR ENTHUSIASM
This article was originally published in The Gray Sheet
Executive SummaryCORDIS' YEAR-END RESULTS FUEL CONTINUED INVESTOR ENTHUSIASM in the company's stock in August as the issue climbs 10 points during the month to 55. Most of the 22.2% gain was realized following Cordis' Aug. 24 release of fourth quarter and year-end sales and earnings figures; the stock advanced 6-1/4 points in the month's final week.
You may also be interested in...
Less-invasive technologies to treat benign prostatic hyperplasia are fast becoming viable alternatives to medication and surgery. Here's what one researcher in the area, Steven Raman, had to say about the new options.
Novartis’s first digital innovation hub in Asia is launched in India, where the Swiss company hopes to ally with partners to deliver digital solutions for patients at scale.
Senate Finance Committee’s approach to penalize companies for raising WAC list prices is not a ‘price control,’ but a reasonable approach to change the incentives that distort pricing in the supply chain, US HHS Secretary Alex Azar says.